Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe cheapest Mounjaro price available privately in the UK depends on the dose and the provider, but since Eli Lilly raised its UK list price on 1 September 2025, typical private monthly costs range from roughly £149 to £375 — reported figures that shift by dose and pharmacy. Mounjaro is a prescription-only medicine; no legitimate route to it exists without a clinical assessment by a qualified prescriber. What varies between providers is not just the number on the page, but what that number actually covers.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Eli Lilly's decision to raise its UK list price on 1 September 2025 reshaped what private providers charge. Before that date the highest-dose pen carried a list price of around £122 for four weeks; after it, that same pen's list price rose to around £330. Across the market, reported private prices now range broadly from roughly £149 a month at starter doses to around £375 at the top of the schedule, figures widely covered in the press at the time and consistent with what Lilly UK communicated.
Those figures are hedged for good reason: individual providers set their own retail prices above list, and the gap between them is real. What the number on a comparison site rarely tells you is whether a consultation fee, a prescription charge, a delivery fee, or an ongoing support cost is baked in or added at checkout. For more detail on how the market has moved, the Mounjaro price news page tracks the latest changes as they happen.
NICE's appraisal of tirzepatide, TA1026, sets out the clinical evidence base and the NHS commissioning criteria, worth reading if you want to understand why this medicine carries the price it does. The trial data from SURMOUNT-1, published in the New England Journal of Medicine, reported average body-weight reductions of around 20–21% at the 15mg dose over 72 weeks. That kind of clinical outcome is what the price reflects.
A low monthly figure can look compelling until you add up the extras. Some providers charge separately for the initial consultation, sometimes £30–£50 before a prescription is written. Others add a dispensing or prescription fee on top of the medicine cost. Delivery, if it is not free, can run to £10–£15 per order for cold-chain-compliant next-day courier services, which injectable medicines require. Aftercare (the clinical support you need if you experience side effects or want to discuss a dose change) may be an optional paid add-on rather than something included as standard.
None of this is a criticism of any specific provider. It is consumer education: when you are comparing Mounjaro prices across the UK market, the relevant question is what the total cost of a supervised month of treatment looks like, not what the pen costs in isolation. A provider that charges less per pen but bills separately for every clinical interaction may not be cheaper in practice.
The dose also changes the maths significantly. Starter-dose costs at 2.5mg and the first therapeutic step at 5mg are meaningfully lower than the higher rungs. Most people do not stay at the starting dose for long (titration is guided by the prescriber) so it is worth understanding the full-schedule picture rather than anchoring to the entry-level figure.
One transparent price at nume covers the consultation, the prescription, the medicine, free next-working-day tracked delivery by DPD, and seven-day aftercare. There are no hidden fees, no subscription, and no auto-renewal, every repeat order is clinically re-reviewed before anything is dispensed. Current pricing is shown on the treatment page, and it updates there when it changes.
We are not the cheapest option on the market, and that is deliberate. The clinical infrastructure behind every order (photo-ID and live weight verification, Summary Care Record checks where appropriate, a GPhC-registered Independent Prescriber reading every consultation, GP notification in line with GPhC guidance) costs money to run properly. Cutting corners on those steps would cut costs too. We chose not to.
Our pharmacy is GPhC-registered (premises number 9012878, verifiable at the GPhC register), and Mounjaro is sourced through the licensed UK supply chain. If you want to understand more about the service behind the prescription, the about us page sets it out plainly. For a deeper look at how to find genuinely competitive pricing without sacrificing safety, the cheapest Mounjaro UK guide is worth a read.
Mounjaro requires a cold chain from manufacturer to patient: the pen lives in a fridge between 2–8°C (the same shelf as the milk, typically) and any break in that chain affects the medicine. Counterfeit and unregulated supply is a documented problem. The MHRA has issued repeated public warnings about fake weight-loss pens; in October 2025 the first UK site manufacturing counterfeit tirzepatide pens was raided in Northampton, and enforcement through 2025 involved roughly 20 million doses of illegally traded weight-loss medicines with a street value of around £45 million. Sellers offering these medicines without a prescription, via social media, or at prices far below the reported market range are the red flags the MHRA's Yellow Card service asks you to report.
The right metric for a prescription medicine is not the cheapest listing. It is whether the supply chain is genuine, whether a real clinician reviewed your suitability, and whether clinical support exists if something goes wrong. Those things are not luxuries, they are what makes the treatment safe. If you are weighing up the options and want to look at dose-level cost in more detail, the 15mg cost guide and the per-pen breakdown each cover their ground thoroughly. When you are ready to take the clinical step, a prescriber is available the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.